SC
VRTX icon

Sepio Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Sepio Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.7M Sell
8,294
-571
-6% -$266K 0.2% 66
2025
Q4 		$4.02M Sell
8,865
-198
-2% -$85.3K 0.22% 67
2025
Q3 		$3.55M Buy
9,063
+716
+9% +$299K 0.21% 67
2025
Q2 		$3.72M Sell
8,347
-13
-0.2% -$5.99K 0.26% 65
2025
Q1 		$4.05M Buy
8,360
+1,311
+19% +$611K 0.32% 53
2024
Q4 		$2.84M Buy
7,049
+18
+0.3% +$8.34K 0.23% 81
2024
Q3 		$3.27M Sell
7,031
-64
-0.9% -$30.7K 0.25% 71
2024
Q2 		$3.33M Sell
7,095
-45
-0.6% -$19.5K 0.3% 61
2024
Q1 		$2.98M Sell
7,140
-168
-2% -$71K 0.26% 81
2023
Q4 		$2.97M Sell
7,308
-1,483
-17% -$548K 0.25% 79
2023
Q3 		$3.06M Buy
8,791
+112
+1% +$39.2K 0.26% 80
2023
Q2 		$3.05M Sell
8,679
-425
-5% -$143K 0.25% 110
2023
Q1 		$2.87M Sell
9,104
-2,057
-18% -$617K 0.26% 112
2022
Q4 		$3.22M Sell
11,161
-2,349
-17% -$716K 0.28% 95
2022
Q3 		$3.91M Sell
13,510
-1,050
-7% -$302K 0.39% 81
2022
Q2 		$4.1M Sell
14,560
-5,007
-26% -$1.34M 0.41% 76
2022
Q1 		$5.11M Sell
19,567
-1,595
-8% -$379K 0.45% 69
2021
Q4 		$4.65M Buy
21,162
+333
+2% +$64.8K 0.34% 83
2021
Q3 		$3.78M Buy
+20,829
New +$4.07M 0.31% 100

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sepio Capital's VRTX Position: Q1 2026 in Review

Sepio Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 6.4% in Q1 2026, selling an estimated $266K and leaving 8,294 shares worth $3.7M. The position accounts for 0.2% of the portfolio, ranked #66.

Sepio Capital first reported a position in VRTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.11M in Q1 2022. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Sepio Capital held 8,294 shares of Vertex Pharmaceuticals worth $3.7M as of Q1 2026.
  • Sepio Capital sold 571 Vertex Pharmaceuticals shares in Q1 2026, an estimated $266K.
  • Vertex Pharmaceuticals made up 0.2% of Sepio Capital's portfolio in Q1 2026, its #66 holding.
  • Sepio Capital first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Sepio Capital's Vertex Pharmaceuticals position peaked at $5.11M in Q1 2022.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.